Innovation of clinical trials in China: Commentary on the publication of “CONSORT extension for Chinese herbal medicine formulas 2017: Recommendations, explanation, and elaboration”

Taixiang Wu; Zhaoxiang Bian; Hongcai Shang; Youping Li

doi:10.1111/jebm.12268

Innovation of clinical trials in China: Commentary on the publication of “CONSORT extension for Chinese herbal medicine formulas 2017: Recommendations, explanation, and elaboration”

Taixiang Wu
, Zhaoxiang Bian
, Hongcai Shang
, Youping Li^*

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

8 Citations (Scopus)

Original language	English
Pages (from-to)	155-162
Number of pages	8
Journal	Journal of Evidence-Based Medicine
Volume	10
Issue number	3
DOIs	https://doi.org/10.1111/jebm.12268
Publication status	Published - Aug 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

User-Defined Keywords

checklist
Chinese herbal medicine formulas
clinical trial
CONSORT
data sharing
reporting guideline

Access to Document

10.1111/jebm.12268

Cite this

@article{04ae0114affb48b09fb5c91275e93ce6,

title = "Innovation of clinical trials in China: Commentary on the publication of “CONSORT extension for Chinese herbal medicine formulas 2017: Recommendations, explanation, and elaboration”",

keywords = "checklist, Chinese herbal medicine formulas, clinical trial, CONSORT, data sharing, reporting guideline",

author = "Taixiang Wu and Zhaoxiang Bian and Hongcai Shang and Youping Li",

year = "2017",

month = aug,

doi = "10.1111/jebm.12268",

language = "English",

volume = "10",

pages = "155--162",

journal = "Journal of Evidence-Based Medicine",

issn = "1756-5383",

publisher = "John Wiley \& Sons Ltd",

number = "3",

}

Innovation of clinical trials in China: Commentary on the publication of “CONSORT extension for Chinese herbal medicine formulas 2017: Recommendations, explanation, and elaboration”. / Wu, Taixiang; Bian, Zhaoxiang; Shang, Hongcai et al.
In: Journal of Evidence-Based Medicine, Vol. 10, No. 3, 08.2017, p. 155-162.

Research output: Contribution to journal › Review article › peer-review

TY - JOUR

T1 - Innovation of clinical trials in China

T2 - Commentary on the publication of “CONSORT extension for Chinese herbal medicine formulas 2017: Recommendations, explanation, and elaboration”

AU - Wu, Taixiang

AU - Bian, Zhaoxiang

AU - Shang, Hongcai

AU - Li, Youping

PY - 2017/8

Y1 - 2017/8

KW - checklist

KW - Chinese herbal medicine formulas

KW - clinical trial

KW - CONSORT

KW - data sharing

KW - reporting guideline

UR - https://www.scopus.com/pages/publications/85028570370

U2 - 10.1111/jebm.12268

DO - 10.1111/jebm.12268

M3 - Review article

C2 - 28857507

AN - SCOPUS:85028570370

SN - 1756-5383

VL - 10

SP - 155

EP - 162

JO - Journal of Evidence-Based Medicine

JF - Journal of Evidence-Based Medicine

IS - 3

ER -

Innovation of clinical trials in China: Commentary on the publication of “CONSORT extension for Chinese herbal medicine formulas 2017: Recommendations, explanation, and elaboration”

UN SDGs

User-Defined Keywords

Access to Document

Other files and links

Cite this